Correlation between glycemic control and dyslipidemia in Type 2 Diabetes Mellitus patient
Loading...
Date
2019-06
Journal Title
Journal ISSN
Volume Title
Publisher
Medip Academy
Abstract
Background: India is one of the countries with highest number of diabetes patients. Patients of type 2 diabetes mellitus are usually dyslipidemic. The objective of the research was to study the pattern of dyslipidemia and to study the correlation of glycemic control with dyslipidemia in type 2 diabetes mellitus patients.Methods: A cross sectional observational study was performed on patients of type 2 diabetes mellitus over 6 months period. The study included 200 patients and the variables recorded were demographic profile, FBS, PPBS, HbA1C and lipid profile parameters. The patients were divided into 3 groups according to HbA1C level i.e. Group I (Good glycemic control HbA1C 6-7 gm%), group II (Fair glycemic control HbA1C 7.1-8.2 gm%) and group III (poor glycemic control, HbA1C >8.2 gm%).Results: The data showed that TG level was maximum in group III and was minimum in group I. Comparison between the group shows a significant difference between all the groups (P <0.001). A significant positive correlation (Correlation coefficient 0.67, P <0.001) was also observed between level of TG and HbA1C. Similarly, LDL level was also highest in group III with a significant difference with other two groups (P <0.05). Also, a positive correlation (Correlation coefficient 0.64, P <0.05) was observed between LDL and HbA1C. On the other hand, HDL was lowest in group III as compared to groups I and II (P <0.001) and a negative correlation (Correlation coefficient -0.716, P <0.001) was seen between HDL and HbA1C.Conclusions: Dyslipidemia is less prevalent in diabetics who have better glycemic control.
Description
Keywords
Dyslipidemia, Glycemic control, HbA1C, Type 2 diabetes mellitus
Citation
Yadav Neha, Singh Sujata, Gupta Smita, Mishra Saurabh, Singh Krishna. Correlation between glycemic control and dyslipidemia in Type 2 Diabetes Mellitus patient. International Journal of Basic & Clinical Pharmacology. 2019 Jun; 8(6): 1387-1392